Article info

Download PDFPDF

Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain)

Authors

  1. Correspondence to Dr Francesca L Beaudoin; Francesca_Beaudoin{at}brown.edu
View Full Text

Citation

Strauss DH, Santhanam DR, McLean SA, et al
Study protocol for a randomised, double-blind, placebo-controlled clinical trial of duloxetine for the treatment and prevention of musculoskeletal pain: altering the transition from acute to chronic pain (ATTAC pain)

Publication history

  • Received June 25, 2018
  • Revised December 3, 2018
  • Accepted January 22, 2019
  • First published March 5, 2019.
Online issue publication 
March 05, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.